Ken Griffin Nanobiotix S.A. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding NBTX
# of Institutions
13Shares Held
9.31MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$29.8 Million7.7% of portfolio
-
Baillie Gifford & CO2.87MShares$15.2 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY555KShares$2.94 Million0.08% of portfolio
-
Black Rock Inc. New York, NY253KShares$1.34 Million0.0% of portfolio
-
Ubs Group Ag3.1KShares$16,4300.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $185M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...